Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2081-2090 of 10942

Edit search filters
  1. Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation

    Rochester, MN

  2. A Study to Evaluate the Pharmacokinetics of Low-Dose Bevacuzimab in Reducing Free Plasma VEGF-A in Hemodialysis Patients

    Rochester, MN

  3. Prehospital Tranexamic Acid Use for Traumatic Brain Injury

  4. A Study to Detect Upper Gastrointestinal Bleeding Using a Bleeding Sensor Pill

    Rochester, MN

  5. A Study to Evaluate the Safety and Effectiveness of TT-00420 in Adults with Advanced Cholangiocarcinoma

    Rochester, MN

  6. Acetylsalicylic Acid in Preventing Disease Recurrence in Patients With Barrett's Esophagus After Successful Elimination by Radiofrequency Ablation

    Rochester, MN

  7. ATTR Expanded Access Program (EAP) by Ionis

    Rochester, MN

  8. Comparing MRI to CT on Pediatric Craniosynostosis.

    Rochester, MN

  9. Study of Sparsentan in Patients with Primary Focal Segmental Glomerulosclerosis

    Rochester, MN

  10. A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML

    Rochester, MN

.

Mayo Clinic Footer